Gary Phillips is no longer serving as a Member of the Board

Zyla Life Sciences is a commercial-stage company, which focuses on developing, manufacturing and commercializing innovative treatments for pain. It is focused on bringing non-narcotic products and abuse-discouraging formulations of opioids to patients and healthcare providers. The company plans to continue to grow revenue of its seven commercial products, which includes Sprix nasal spray, Vivlodex, Zorvolex, Tivorbex, Indocin suppositories, Indocin oral suspension and oxaydo tablets, and explore business development opportunities. Zyla Life Sciences was founded in August 2013 and is headquartered in Wayne, PA.

In The News

Assertio Reports Fourth Quarter and Full Year 2020 Financial Results

Mar 11, 2021 - GlobeNewswire

Global Gynecology Partnering Report 2020: Access Deals Signed Between the World's Leading Pharmaceutical and Biotechnology Companies Since 2010

Dec 23, 2020 - PR Newswire

External Ventricular Drain Market Research Report by Indication, by End-User - Global Forecast to 2025 - Cumulative Impact of COVID-19

Dec 01, 2020 - GlobeNewswire